BeStock  

Supernus Pharmaceuticals SUPN

US equityMarket cap rank #2627Drug Manufacturers - Specialty & Generic
$42.76 +$0.38 (+0.90%)
Market closed · Oct 6, 4:30 am ET · Last extended-hours $42.76 0.00%
Open$42.38
Prev close$42.38
Day range$42.38 – $43.20
Volume1.29M
Market cap$2.49B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$65.25+52.6% vs. price
  • Buy 100%
Low $63.00Now $42.76Avg $65.25High $67.00

Recent rating changes

The last 20 actions on file set price targets from $55.00 to $67.00, averaging $64.15.

DateFirmRatingTarget
3 Aug 2026 TD Cowen BUY $65.00
27 Jul 2026 Piper Sandler BUY $66.00
13 Jul 2026 BofA Securities BUY $63.00
9 Jul 2026 Cantor Fitzgerald BUY $67.00
4 Jun 2026 Piper Sandler BUY $66.00
6 May 2026 Piper Sandler BUY $66.00
6 May 2026 Stifel HOLD $55.00
5 May 2026 TD Cowen BUY $65.00
27 Apr 2026 Piper Sandler BUY $66.00
23 Apr 2026 TD Cowen BUY $65.00
13 Apr 2026 Piper Sandler BUY $66.00
25 Feb 2026 TD Cowen BUY $65.00
25 Feb 2026 Stifel HOLD $55.00
24 Feb 2026 TD Cowen BUY $65.00
24 Feb 2026 Cantor Fitzgerald BUY $63.00
24 Feb 2026 BofA Securities BUY $65.00
6 Feb 2026 BofA Securities BUY $65.00
28 Jan 2026 Piper Sandler BUY $65.00
20 Jan 2026 BofA Securities BUY $65.00
9 Jan 2026 Piper Sandler BUY $65.00

Discussion

No comments yet — be the first to weigh in on SUPN.

Leave a comment

Scroll to Top